
NuPotential, a biopharmaceutical firm, develops versatile cell lines for therapies combating major diseases and drug discovery.
Founded in Baton Rouge, LA, NuPotential is a biopharmaceutical company dedicated to developing dedifferentiated cell lines that can be re-differentiated into multiple lineages. Their core mission is to create innovative therapies to reverse the debilitating effects of diseases such as diabetes, stroke, heart disease, Alzheimer's, and Parkinson's. Additionally, they provide advanced cell lines for drug discovery applications, aiming to revolutionize treatment options and enhance medical research.
NuPotential operates out of the Louisiana Emerging Technology Center and has garnered attention for its pioneering work in cellular therapy. The company has made significant strides in the biopharmaceutical industry, contributing to both therapeutic advancements and drug discovery tools. Their impact is reflected in their ability to address critical health challenges and support scientific innovation, positioning them as a key player in the field of regenerative medicine.

Nuon Therapeutics

Neurona Therapeutics

Neuronascent
neuronascent.com

LaCell

Cellebration Life Sciences

Nuo Therapeutics
nuot.com

Novoron Bioscience
novoron.com

NeyroblastGX
neyroblastgx.com

Neuraly
neuralymed.com

NuSirt Sciences
nusirt.com

NeuroGenetic Pharmaceuticals

Cellular Approaches

Neurodon
neurodon.net

Convalesce
convalesce.co

Nuveta
nuveta.com
Companies similar to NuPotential include Nuon Therapeutics, Neurona Therapeutics, Neuronascent and LaCell.
NuPotential was founded in 2004.
NuPotential's headquarters is located in Baton Rouge, LA, US.
NuPotential's most recent funding round was for $375k (USD) in March 2014.
As of Mar 5, 2014, NuPotential has raised a total of $725k (USD).
NuPotential has 8 employees as of Feb 5, 2024.